Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00661_DB06207_nanopub.RAYbei02nC21_UxkeXDCXaW0OMdc5DQez1Wo9NT8uP4WQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00661_DB06207 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB06207 label "DDI between Verapamil and Silodosin - Verapamil is a moderate inhibitor of CYP3A4 and inhibits P-glycoprotein thus increasing the potential for adverse effects [drugbank_resource:DB00661_DB06207]" assertion.
- drugbank_resource:DB00661_DB06207 identifier "drugbank_resource:DB00661_DB06207" assertion.
- drugbank_resource:DB00661_DB06207 title "DDI between Verapamil and Silodosin - Verapamil is a moderate inhibitor of CYP3A4 and inhibits P-glycoprotein thus increasing the potential for adverse effects" assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB06207 assertion.
- drugbank:DB06207 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB06207 assertion.